Regeneron Focuses On COVID-19 Cure

The war on COVID-19 isn't being waged on a distant shore; it's being waged in laboratories. Drug manufacturer Regeneron is answering the call to action and is working closely with regulators to create a viable therapy for the novel virus. David Weinrich, head of global clinical development, describes the “shared sense of urgency” that is driving the work of international governments, agencies, and private companies to develop a way to curb the coronavirus...